The protective effects of a combination of antioxidants on histopathological changes and biochemical parameters were examined in D-galactosamine (D-GaIN)-induced hepatotoxicity in rats. Physiological saline solution was injected intraperitoneally into the control group, while D-GaIN (500 mg kg -1 ) was administered intraperitoneally into the experimental animals. The combination of 100 mg/kg/day ascorbic acid, 100 mg/kg/day alpha tocopherol, 15 mg/kg/day beta carotene, and 0.2 mg/kg/day sodium selenate was administered orally to intact control rats for 3 days. The same antioxidant combination was given to the D-GaIN group. Liver and blood samples were used for histopathological and biochemical assays. Liver tissues were significantly damaged by D-GaIN administration based on the histopathological findings. Serum aspartate and alanine transaminase, gamma glutamyl transpeptidase, alkaline phosphatase, lactate dehydrogenase, sialic acid, and uric acid levels increased. Serum and liver glutathione levels decreased, and serum superoxide dismutase, glutathione peroxidase, and glutathione-S-transferase, catalase activities as well as lipid peroxidation values increased in the D-GaIN group. In contrast, administration of the antioxidants reversed the histopathological and biochemical changes in the liver of animals administered D-GaIN. In conclusion, the administration of a combination of antioxidants suppressed histopathological changes and biochemical parameters in rats given D-GaIN.
INTRODUCTION
Acute liver failure is the rapid development of hepatocellular dysfunction triggering a cascade of events that damages multiple organs. Various agents, such as acetaminophen, hepa wash, and concanavalin cause acute liver damage in animal models, and D-galactosamine (D-GaIN) is a well-established model in experimental animals, such as rats (1) (2) (3) (4) (5) (6) . Several compounds, such as dobutamine, scoparone, polydatin, proline, and triterpenoids are protective against liver failure (7) (8) (9) (10) (11) and the possible role of various antioxidants is under study.
Selenium is a trace element with a significant role in sustaining health. It is a cofactor of glutathione peroxidase (GPx) and protects cells against reactive oxygen species (ROS) (12, 13) . Vitamin C has endogenous antioxidant features, and it has synergistic effects in combination with vitamin E that protect low-density lipoprotein from oxidative stress induced by peroxyl radicals (14, 15) . Vitamin E serves as a free radical scavenger that protects fatty acids in bio-membranes and lipoproteins (16) . Similarly, β-carotene is a major source of retinoids (vitamin A) in the human diet (17) . The protective roles of selenium, vitamin C, and vitamin E either alone or in combination against hepatitis have been described previously (18, 19) . Poor selenium intake can lead to enhanced levels of ROS and oxidative stress, particularly in patients lacking other antioxidants (e.g., vitamins E and C) (20) . However, the role of selenium and the antioxidant combination (vitamins A, C, and E) has not been studied in terms of biochemical and histological impact.
Biochemical Assays
Blood and liver samples were taken from the animals. Serum and liver tissue samples were frozen until use. The18 h-fasting blood and liver glutathione levels were assayed according to Beutler (1975) (21) . AST, ALT (22) , ALP (23) , GGT (24) , LDH (25) , sialic acid, (26) and uric acid levels (27) were assayed in serum samples. Protein levels were estimated by the Lowry method (28).
Tissue samples were homogenized in cold 0.9% NaCl to prepare the 10% (w/v) homogenates. The homogenates were centrifuged, and the supernatants were removed. CAT (29) , SOD (30), GST (31) , and GPx (32, 33) activities were assayed in appropriately diluted liver tissue homogenates. LPO levels in liver homogenates were assayed according to Ledwozyw et al. (34) .
Statistical Analysis
The biochemical results were analyzed using NCSS statistical software (NCSS Inc.; Kaysville, UT, USA). All data are expressed as mean±standard deviation. A p-value <0.05 was considered significant.
RESULTS

Light Microscopic Results
Liver tissues from animals given saline or the antioxidants (groups 1 and 2, respectively) had normal histology except for vacuolization that was observed in liver cells from group 2 (data not shown). The D-GalN-injected rats (group 3) had significant histopathological changes in the liver (Figure 1 ). Increased hyperemia, moderate vacuolization, enlargement in the sinusoidal area, necrotic, and swollen cells with a light cytoplasm were observed in the D-GaIN group vs. control groups 1 and 2. Administering selenium and the antioxidants reversed the histopathological changes in D-GaIN-injected animals. A decrease in mononuclear cell infiltration and hyperemia was observed in group 4 animals. However, vacuolization was observed in group 2 animals. These results indicate that administering selenium and the antioxidants may suppress the histological changes, except vacuolization in the liver of D-GaIN-injected rats.
Biochemical Results
Changes in serum AST, ALT, ALP, and GGT in the control and experimental groups are shown in Table 1 . Serum AST (p<0.0001), ALT (p<0.0001), ALP (p<0.0001), and GGT (p<0.0001) activities were significantly higher in the D-GalN group compared to those in the control group. Administering the antioxidants significantly decreased serum AST (p<0.005), ALT (p<0.05), ALP (p<0.05), and GGT (p<0.005) activities in the D-GalN group (Table 1).
Blood GSH levels and serum LDH and CAT activities for all groups are shown in Table 2 . Blood GSH values were significantly lower in the experimental group compared to those in the control group (p<0.0001), but CAT activity did not change. A significant increase in serum LDH activity was observed in the D-GalN group (p<0.005) compared with control rats. Administering antioxidants significantly increased blood GSH levels (p<0.0001) and CAT (p<0.005) activity, but decreased LDH activity in the D-GalN group (p<0.0001, Table 2 ).
Serum sialic acid and uric acid levels were significantly higher in the D-GalN group compared with those in the control group (p<0.0001) ( Table 3) . Antioxidant administration caused a significant decrease in mean serum sialic acid (p<0.0001) and uric acid (p<0.005) values in the D-GalN group compared with those in the control group (Table 3) .
Liver GSH (p<0.005), CAT (p<0.05), SOD (p<0.05), and GPx (p<0.05) activities decreased significantly in the D-GalN group, compared to those in the control group. Liver GST activity also tended to decrease but not significantly. Tissue LPO levels increased in the D-GalN group compared to those in the control group (p<0.005). Administering the antioxi-dants significantly increased tissue GSH level (p<0.0001) and CAT (p<0.05), SOD (p<0.005,) and GPx (p<0.0001) activities in the D-GalN group. Liver GST activity did not change. Liver LPO level decreased significantly in the D-GaIN+antioxidant group (p<0.005) ( Table 4) .
DISCUSSION
Acute liver failure significantly affects many bodily functions (35) . Animal models of liver injury have been used to study acute liver failure, and D-GaIN administration is a good liver failure model (36) . Other organs are affected by D-GaIN administration (37). D-GaIN accelerates oxidative stress by increasing ROS production (36, 37) . Administering D-GaIN consumes antioxidant compounds in the liver (38) .
Administering D-GaIN generated free radicals that stimulated LPO. D-GalN in combination with lipopolysaccharide treatment induces hepatotoxicity and significantly increase all markers of liver injury and LPO (39) . Several researchers have suggested that various compounds, such as flavonoids, lycopene, and magniferin, ameliorate D-GaIN-induced acute liver injury due to their antioxidant activities (40-42). Therefore, it can be in- Our results show that administering selenium and the antioxidants prevented histopathological liver damage in the D-GalN group. Similarly, the use of antioxidant compounds, such as vitamin E ameliorated oxidative damage in tissues including the liver. Gezginci-Oktayoglu et al. (43) reported that a combination of selenium and vitamins C and E has a curative effect on hepatic damage. Ghrelin also improves the histopathological changes in the liver (44) . Wild ginseng cambial meristematic cells protect the liver against GalN-induced inflammation, and sesamin ameliorates D-GaIN/lipopolysaccharide-induced hepatic damage (45, 46) . Forsythiaside has also been reported as a protective compound against lipopolysaccharide (LPS)/DGalN-induced liver injury (47) . Genistein maintains the redox potential and improves the antioxidant defense system of cells to prevent hepatic and inflammatory diseases (48). Aristatile et al. (49) reported that carvacrol has hepatoprotective effects and alleviates liver injury caused by D-GalN-induced hepatotoxicity in rats. Li et al. (50) determined that linalool protects against liver damage induced by LPS/D-GalN through induction by antioxidants.
Various researchers have demonstrated enhanced antioxidant enzymatic activities in livers damaged by D-GaIN. Ai et al. (51) showed increased liver enzymatic activities, including SOD, GPx, and CAT caused by the phenolics obtained from Oenanthe javanica. Similarly, one study showed that rats injected with D-GalN/LPS develop hepatic damage, and AST and ALT levels increase significantly (36) . Blood urea nitrogen also changes in the liver of rats after treatment with D-GaIN/LPS (52). Ozden et al. (53) reported that vitamin E and taurine treatment significantly decreases tissue LPO levels.
Gezginci-Oktayoglu et al. (54) determined that oxidative stress decreases and antioxidant enzyme systems increase in response to administration of a Beta vulgaris L. var.cicla extract to injured rats based on decreased malondialdehyde formation (LPO), CAT activity, SOD, myeloperoxidase, and increased GSH levels in the liver. Similar biochemical results were reported in other organs, such as lungs injured by D-GaIN. The lung tissue damage occurred in D-GalN/tumor necrosis factor-alpha administered animals. Lung damage improves with the administration of Z-FA. FMK (55) . Similarly, our results indicate that increased levels of serum AST, ALT, ALP, GGT, LDH, LPO, serum sialic acid, and uric acid were due to D-GaIN administration, which decreased liver CAT, SOD, GST, and GPx activities as well as blood and liver GSH levels. Liver LPO levels increased in the D-GalN group. Treat- 
